Prostate cancer incidence across stage, NCCN risk groups, and age before and after USPSTF Grade D recommendations against prostate‐specific antigen screening in 2012

Screening for Prostate Cancer

(2018) et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Increase in Prostate Cancer Distant Metastases at Diagnosis in the United States

(2017) Jim C. Hu et al.   JAMA Oncology

Prostate Cancer Incidence Rates 2 Years After the US Preventive Services Task Force Recommendations Against Screening

(2016) Ahmedin Jemal et al.   JAMA Oncology

The Pendulum of Prostate Cancer Screening

(2015) David F. Penson   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations

(2015) Ahmedin Jemal et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

(2014) Fritz H Schröder et al.   LANCET

Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement

(2013)   ANNALS OF INTERNAL MEDICINE

Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement

(2013) Virginia A. Moyer   ANNALS OF INTERNAL MEDICINE

Mortality Results from a Randomized Prostate-Cancer Screening Trial

(2009) Gerald L. Andriole et al.   NEW ENGLAND JOURNAL OF MEDICINE

Screening and Prostate-Cancer Mortality in a Randomized European Study

(2009) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE